iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/23334629/
Tumefactive demyelination: an approach to diagnosis and management - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;84(9):1047-53.
doi: 10.1136/jnnp-2012-304498. Epub 2013 Jan 19.

Tumefactive demyelination: an approach to diagnosis and management

Affiliations
Review

Tumefactive demyelination: an approach to diagnosis and management

Todd A Hardy et al. J Neurol Neurosurg Psychiatry. 2013 Sep.

Abstract

Tumefactive lesions are an uncommon manifestation of demyelinating disease and can pose a diagnostic challenge in patients without a pre-existing diagnosis of multiple sclerosis. Choosing when to biopsy a tumefactive lesion to exclude alternative pathology can be difficult. Other questions include how best to treat an acute attack as well as the optimal timing of therapy to prevent relapse. This article aims to review the available literature for tumefactive demyelination and to propose an approach to diagnosis and management. We argue that disease modifying therapy should be considered for acute tumefactive demyelinating lesions only once criteria of dissemination in time and space are fulfilled and the diagnosis of multiple sclerosis is confirmed.

Keywords: Multiple Sclerosis; Neuroimmunology; Neuropathology; Neuroradiology; Tumours.

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources